Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
Identifieur interne : 000873 ( Pmc/Curation ); précédent : 000872; suivant : 000874Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
Auteurs : Karlynn E. Neu [États-Unis] ; Carole J. Henry Dunand [États-Unis] ; Patrick C. Wilson [États-Unis]Source :
- Current opinion in immunology [ 0952-7915 ] ; 2016.
Abstract
Current seasonal influenza virus vaccines are effective against infection but they have to be reformulated on a regular basis to counter antigenic variations. The majority of the antibodies induced in response to seasonal vaccination are strain-specific. However, antibodies targeting conserved epitopes on the hemagglutinin protein have been identified and they offer broad protection. Most of these antibodies bind the hemagglutinin stalk domain and are generated from preexisting memory B cells. Broadly protective stalk-biased responses induced by antigenically divergent influenza strains, in concert with prior immunity, are sufficient to eradicate seasonally circulating strains. Future vaccine trials should aim to harness and maintain such a response with the realistic goal of developing a universal influenza vaccine.
Url:
DOI: 10.1016/j.coi.2016.05.012
PubMed: 27268395
PubMed Central: 5086271
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000873
Links to Exploration step
PMC:5086271Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?</title><author><name sortKey="Neu, Karlynn E" sort="Neu, Karlynn E" uniqKey="Neu K" first="Karlynn E." last="Neu">Karlynn E. Neu</name><affiliation wicri:level="1"><nlm:aff id="A1">Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Committee on Immunology, The University of Chicago, Chicago, IL 60637</wicri:regionArea></affiliation></author><author><name sortKey="Henry Dunand, Carole J" sort="Henry Dunand, Carole J" uniqKey="Henry Dunand C" first="Carole J." last="Henry Dunand">Carole J. Henry Dunand</name><affiliation wicri:level="1"><nlm:aff id="A2">The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637</wicri:regionArea></affiliation></author><author><name sortKey="Wilson, Patrick C" sort="Wilson, Patrick C" uniqKey="Wilson P" first="Patrick C." last="Wilson">Patrick C. Wilson</name><affiliation wicri:level="1"><nlm:aff id="A1">Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Committee on Immunology, The University of Chicago, Chicago, IL 60637</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A2">The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">27268395</idno><idno type="pmc">5086271</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086271</idno><idno type="RBID">PMC:5086271</idno><idno type="doi">10.1016/j.coi.2016.05.012</idno><date when="2016">2016</date><idno type="wicri:Area/Pmc/Corpus">000873</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000873</idno><idno type="wicri:Area/Pmc/Curation">000873</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000873</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?</title><author><name sortKey="Neu, Karlynn E" sort="Neu, Karlynn E" uniqKey="Neu K" first="Karlynn E." last="Neu">Karlynn E. Neu</name><affiliation wicri:level="1"><nlm:aff id="A1">Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Committee on Immunology, The University of Chicago, Chicago, IL 60637</wicri:regionArea></affiliation></author><author><name sortKey="Henry Dunand, Carole J" sort="Henry Dunand, Carole J" uniqKey="Henry Dunand C" first="Carole J." last="Henry Dunand">Carole J. Henry Dunand</name><affiliation wicri:level="1"><nlm:aff id="A2">The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637</wicri:regionArea></affiliation></author><author><name sortKey="Wilson, Patrick C" sort="Wilson, Patrick C" uniqKey="Wilson P" first="Patrick C." last="Wilson">Patrick C. Wilson</name><affiliation wicri:level="1"><nlm:aff id="A1">Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Committee on Immunology, The University of Chicago, Chicago, IL 60637</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A2">The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637</wicri:regionArea></affiliation></author></analytic><series><title level="j">Current opinion in immunology</title><idno type="ISSN">0952-7915</idno><idno type="eISSN">1879-0372</idno><imprint><date when="2016">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P2">Current seasonal influenza virus vaccines are effective against infection but they have to be reformulated on a regular basis to counter antigenic variations. The majority of the antibodies induced in response to seasonal vaccination are strain-specific. However, antibodies targeting conserved epitopes on the hemagglutinin protein have been identified and they offer broad protection. Most of these antibodies bind the hemagglutinin stalk domain and are generated from preexisting memory B cells. Broadly protective stalk-biased responses induced by antigenically divergent influenza strains, in concert with prior immunity, are sufficient to eradicate seasonally circulating strains. Future vaccine trials should aim to harness and maintain such a response with the realistic goal of developing a universal influenza vaccine.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">8900118</journal-id><journal-id journal-id-type="pubmed-jr-id">1461</journal-id><journal-id journal-id-type="nlm-ta">Curr Opin Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Curr. Opin. Immunol.</journal-id><journal-title-group><journal-title>Current opinion in immunology</journal-title></journal-title-group><issn pub-type="ppub">0952-7915</issn><issn pub-type="epub">1879-0372</issn></journal-meta><article-meta><article-id pub-id-type="pmid">27268395</article-id><article-id pub-id-type="pmc">5086271</article-id><article-id pub-id-type="doi">10.1016/j.coi.2016.05.012</article-id><article-id pub-id-type="manuscript">NIHMS793109</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Neu</surname><given-names>Karlynn E.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Henry Dunand</surname><given-names>Carole J.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Patrick C.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA</aff><aff id="A2"><label>2</label>The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois 60637, USA</aff><author-notes><corresp id="FN1">Corresponding authors: <email>caroledunand@uchicago.edu</email> and <email>wilsonp@uchicago.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>23</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>3</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>10</month><year>2017</year></pub-date><volume>42</volume><fpage>48</fpage><lpage>55</lpage><pmc-comment>elocation-id from pubmed: 10.1016/j.coi.2016.05.012</pmc-comment>
<abstract><p id="P2">Current seasonal influenza virus vaccines are effective against infection but they have to be reformulated on a regular basis to counter antigenic variations. The majority of the antibodies induced in response to seasonal vaccination are strain-specific. However, antibodies targeting conserved epitopes on the hemagglutinin protein have been identified and they offer broad protection. Most of these antibodies bind the hemagglutinin stalk domain and are generated from preexisting memory B cells. Broadly protective stalk-biased responses induced by antigenically divergent influenza strains, in concert with prior immunity, are sufficient to eradicate seasonally circulating strains. Future vaccine trials should aim to harness and maintain such a response with the realistic goal of developing a universal influenza vaccine.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000873 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000873 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Pmc
|étape= Curation
|type= RBID
|clé= PMC:5086271
|texte= Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:27268395" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |